Memory Pharmaceuticals Corp (MEMY)

[surf1944]

Memory Pharmaceuticals to Host R&D Day on May 16, 2008
Monday May 12, 6:05 am ET

MONTVALE, N.J., May 12 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (Nasdaq: MEMY - News), today announced that it will host an R&D Day for the investment community on Friday, May 16, 2008 in New York City. Presentations will begin at 9:00 a.m. EDT and will focus on the Company's progress with its nicotinic alpha-7 receptor agonist collaboration with Roche and its PDE4 inhibitor and 5-HT6 antagonist programs.

Interested parties may access a live webcast of the presentation and accompanying slides by visiting the Investor Relations section of Memory Pharmaceuticals' website at http://www.memorypharma.com. An archived version of the webcast will be available at the same location through May 23, 2008.

For more information on the R&D Day, please e-mail [e-mail].

About the Company

Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders, many of which exhibit significant impairment of memory and other cognitive functions, including Alzheimer's disease and schizophrenia. For additional information, please visit our website at http://www.memorypharma.com.

For More Information:
Jzaneen Lalani Laura Perry
General Counsel LMP Investor Relations
[phone] [phone]